Evidence map›Paper›PMID 38827530›Full record

ArticleUrology case reports2024

An atypical presentation of renal mass associated with BAP-1 tumor predisposition syndrome: Case report and review of literature.

M Alonso Grandes, R Roldán Testillano, A M Márquez Negro, C Cernuda Pereira, M Dorado Valentín, R Khedaoui, A Páez Borda

Abstract readCase Reports
In one paragraph

Article in Urology case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

M Alonso GrandesUniversity Hospital of Fuenlabrada. Department of Urology. Fuenlabrada, Madrid, Spain.
R Roldán TestillanoUniversity Hospital of Fuenlabrada. Department of Urology. Fuenlabrada, Madrid, Spain.
A M Márquez NegroUniversity Hospital of Fuenlabrada. Department of Urology. Fuenlabrada, Madrid, Spain.
C Cernuda PereiraUniversity Hospital of Fuenlabrada. Department of Urology. Fuenlabrada, Madrid, Spain.
M Dorado ValentínUniversity Hospital of Fuenlabrada. Department of Urology. Fuenlabrada, Madrid, Spain.
R KhedaouiUniversity Hospital of Fuenlabrada. Department of Urology. Fuenlabrada, Madrid, Spain.
A Páez BordaUniversity Hospital of Fuenlabrada. Department of Urology. Fuenlabrada, Madrid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BCRA-associated protein-1 (BAP-1) mutation has been associated with the development of a familiar syndrome that predisposes to tumors with a higher incidence than in general population, including melanoma and renal carcinoma. We report a 47-year-old woman diagnosed with a BAPoma (melanocytic tumor characterized by the loss of BAP-1). Due to her extensive family history with multiple neoplasms, a FDG PET-CT was performed. Consequently, she was diagnosed with an atypical renal mass, which is rarely linked to this syndrome. We review and discuss the available literature on the screening, diagnosis and treatment of renal tumors associated with BAP-1 tumor predisposition syndrome.

Indexed as

BAP-1BAPomaOncocytomarenal carcinomaTumor predisposition syndrome

Identifiers

PMID38827530
PMCPMC11143434

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.